Nickel(II) ion (Ni2+)

Nickel(II) ion (Ni2+) is a potent environmental allergen and the primary cause of allergic contact dermatitis (ACD) worldwide [StatPearls, 2023]. It acts as a hapten, binding to endogenous proteins to form antigenic complexes that are processed and presented to T lymphocytes [PubMed, 2016]. A key molecular mechanism involves the direct activation of human Toll-like receptor 4 (TLR4) through the coordination of Ni2+ with specific histidine residues (H431 and H456/H458) in the receptor's extracellular domain [Nature, 2010]. This interaction bypasses the traditional MD-2/LPS binding site, triggering a pro-inflammatory cytokine cascade [PubMed, 2020]. In addition to skin contact, systemic exposure to nickel through diet or medical implants can lead to systemic nickel allergy syndrome (SNAS) [PubMed, 2014]. Therapeutic interventions primarily focus on avoidance, but pharmacological treatments include topical corticosteroids to suppress inflammation and chelating agents like disulfiram to reduce systemic nickel levels [PubChem, 2023]. Research into nickel-specific hypersensitivity has highlighted the importance of innate immune signaling in the sensitization phase of contact allergy [PubMed, 2018].

Other names

Nickel ionNickelous ionNi(II)Nickel allergen

Chelation of nickel ions to form stable, excretable complexes; Inhibition of pro-inflammatory gene expression and cytokine release via glucocorticoid receptor signaling.